Cargando…
Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas
Anaplastic (ATC) and certain follicular thyroid-carcinomas (FTCs) are radioresistant. The Phosphatidylinositide 3-kinase (PI3K) pathway is commonly hyperactivated in thyroid-carcinomas. PI3K can modify the PI3K-related kinases (PIKKs) in response to radiation: How PIKKs interact with PI3K and contri...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325350/ https://www.ncbi.nlm.nih.gov/pubmed/27527858 http://dx.doi.org/10.18632/oncotarget.11056 |
_version_ | 1782510364411297792 |
---|---|
author | Burrows, Natalie Williams, Joseph Telfer, Brian A Resch, Julia Valentine, Helen R Fitzmaurice, Richard J Eustace, Amanda Irlam, Joely Rowling, Emily J Hoang-Vu, Cuong West, Catharine M Brabant, Georg Williams, Kaye J |
author_facet | Burrows, Natalie Williams, Joseph Telfer, Brian A Resch, Julia Valentine, Helen R Fitzmaurice, Richard J Eustace, Amanda Irlam, Joely Rowling, Emily J Hoang-Vu, Cuong West, Catharine M Brabant, Georg Williams, Kaye J |
author_sort | Burrows, Natalie |
collection | PubMed |
description | Anaplastic (ATC) and certain follicular thyroid-carcinomas (FTCs) are radioresistant. The Phosphatidylinositide 3-kinase (PI3K) pathway is commonly hyperactivated in thyroid-carcinomas. PI3K can modify the PI3K-related kinases (PIKKs) in response to radiation: How PIKKs interact with PI3K and contribute to radioresistance in thyroid-carcinomas is unknown. Further uncertainties exist in how these interactions function under the radioresistant hypoxic microenvironment. Under normoxia/anoxia, ATC (8505c) and FTC (FTC-133) cells were irradiated, with PI3K-inhibition (via GDC-0941 and PTEN-reconstitution into PTEN-null FTC-133s) and effects on PIKK-activation, DNA-damage, clonogenic-survival and cell cycle, assessed. FTC-xenografts were treated with 5 × 2 Gy, ± 50 mg/kg GDC-0941 (twice-daily; orally) for 14 days and PIKK-activation and tumour-growth assessed. PIKK-expression was additionally assessed in 12 human papillary thyroid-carcinomas, 13 FTCs and 12 ATCs. GDC-0941 inhibited radiation-induced activation of Ataxia-telangiectasia mutated (ATM), ATM-and Rad3-related (ATR) and DNA-dependent protein kinase catalytic subunit (DNA-PKcs). Inhibition of ATM and DNA-PKcs was PI3K-dependent, since activation was reduced in PTEN-reconstituted FTC-133s. Inhibition of PIKK-activation was greater under anoxia: Consequently, whilst DNA-damage was increased and prolonged under both normoxia and anoxia, PI3K-inhibition only reduced clonogenic-survival under anoxia. GDC-0941 abrogated radiation-induced cell cycle arrest, an effect most likely linked to the marked inhibition of ATR-activation. Importantly, GDC-0941 inhibited radiation-induced PIKK-activation in FTC-xenografts leading to a significant increase in time taken for tumours to triple in size: 26.5 ± 5 days (radiation-alone) versus 31.5 ± 5 days (dual-treatment). PIKKs were highly expressed across human thyroid-carcinoma classifications, with ATM scoring consistently lower. Interestingly, some loss of ATM and DNA-PKcs was observed. These data provide new insight into the mechanisms of hypoxia-associated radioresistance in thyroid-carcinoma. |
format | Online Article Text |
id | pubmed-5325350 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-53253502017-03-23 Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas Burrows, Natalie Williams, Joseph Telfer, Brian A Resch, Julia Valentine, Helen R Fitzmaurice, Richard J Eustace, Amanda Irlam, Joely Rowling, Emily J Hoang-Vu, Cuong West, Catharine M Brabant, Georg Williams, Kaye J Oncotarget Research Paper Anaplastic (ATC) and certain follicular thyroid-carcinomas (FTCs) are radioresistant. The Phosphatidylinositide 3-kinase (PI3K) pathway is commonly hyperactivated in thyroid-carcinomas. PI3K can modify the PI3K-related kinases (PIKKs) in response to radiation: How PIKKs interact with PI3K and contribute to radioresistance in thyroid-carcinomas is unknown. Further uncertainties exist in how these interactions function under the radioresistant hypoxic microenvironment. Under normoxia/anoxia, ATC (8505c) and FTC (FTC-133) cells were irradiated, with PI3K-inhibition (via GDC-0941 and PTEN-reconstitution into PTEN-null FTC-133s) and effects on PIKK-activation, DNA-damage, clonogenic-survival and cell cycle, assessed. FTC-xenografts were treated with 5 × 2 Gy, ± 50 mg/kg GDC-0941 (twice-daily; orally) for 14 days and PIKK-activation and tumour-growth assessed. PIKK-expression was additionally assessed in 12 human papillary thyroid-carcinomas, 13 FTCs and 12 ATCs. GDC-0941 inhibited radiation-induced activation of Ataxia-telangiectasia mutated (ATM), ATM-and Rad3-related (ATR) and DNA-dependent protein kinase catalytic subunit (DNA-PKcs). Inhibition of ATM and DNA-PKcs was PI3K-dependent, since activation was reduced in PTEN-reconstituted FTC-133s. Inhibition of PIKK-activation was greater under anoxia: Consequently, whilst DNA-damage was increased and prolonged under both normoxia and anoxia, PI3K-inhibition only reduced clonogenic-survival under anoxia. GDC-0941 abrogated radiation-induced cell cycle arrest, an effect most likely linked to the marked inhibition of ATR-activation. Importantly, GDC-0941 inhibited radiation-induced PIKK-activation in FTC-xenografts leading to a significant increase in time taken for tumours to triple in size: 26.5 ± 5 days (radiation-alone) versus 31.5 ± 5 days (dual-treatment). PIKKs were highly expressed across human thyroid-carcinoma classifications, with ATM scoring consistently lower. Interestingly, some loss of ATM and DNA-PKcs was observed. These data provide new insight into the mechanisms of hypoxia-associated radioresistance in thyroid-carcinoma. Impact Journals LLC 2016-08-04 /pmc/articles/PMC5325350/ /pubmed/27527858 http://dx.doi.org/10.18632/oncotarget.11056 Text en Copyright: © 2016 Burrows et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Burrows, Natalie Williams, Joseph Telfer, Brian A Resch, Julia Valentine, Helen R Fitzmaurice, Richard J Eustace, Amanda Irlam, Joely Rowling, Emily J Hoang-Vu, Cuong West, Catharine M Brabant, Georg Williams, Kaye J Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas |
title | Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas |
title_full | Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas |
title_fullStr | Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas |
title_full_unstemmed | Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas |
title_short | Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas |
title_sort | phosphatidylinositide 3-kinase (pi3k) and pi3k-related kinase (pikk) activity contributes to radioresistance in thyroid carcinomas |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325350/ https://www.ncbi.nlm.nih.gov/pubmed/27527858 http://dx.doi.org/10.18632/oncotarget.11056 |
work_keys_str_mv | AT burrowsnatalie phosphatidylinositide3kinasepi3kandpi3krelatedkinasepikkactivitycontributestoradioresistanceinthyroidcarcinomas AT williamsjoseph phosphatidylinositide3kinasepi3kandpi3krelatedkinasepikkactivitycontributestoradioresistanceinthyroidcarcinomas AT telferbriana phosphatidylinositide3kinasepi3kandpi3krelatedkinasepikkactivitycontributestoradioresistanceinthyroidcarcinomas AT reschjulia phosphatidylinositide3kinasepi3kandpi3krelatedkinasepikkactivitycontributestoradioresistanceinthyroidcarcinomas AT valentinehelenr phosphatidylinositide3kinasepi3kandpi3krelatedkinasepikkactivitycontributestoradioresistanceinthyroidcarcinomas AT fitzmauricerichardj phosphatidylinositide3kinasepi3kandpi3krelatedkinasepikkactivitycontributestoradioresistanceinthyroidcarcinomas AT eustaceamanda phosphatidylinositide3kinasepi3kandpi3krelatedkinasepikkactivitycontributestoradioresistanceinthyroidcarcinomas AT irlamjoely phosphatidylinositide3kinasepi3kandpi3krelatedkinasepikkactivitycontributestoradioresistanceinthyroidcarcinomas AT rowlingemilyj phosphatidylinositide3kinasepi3kandpi3krelatedkinasepikkactivitycontributestoradioresistanceinthyroidcarcinomas AT hoangvucuong phosphatidylinositide3kinasepi3kandpi3krelatedkinasepikkactivitycontributestoradioresistanceinthyroidcarcinomas AT westcatharinem phosphatidylinositide3kinasepi3kandpi3krelatedkinasepikkactivitycontributestoradioresistanceinthyroidcarcinomas AT brabantgeorg phosphatidylinositide3kinasepi3kandpi3krelatedkinasepikkactivitycontributestoradioresistanceinthyroidcarcinomas AT williamskayej phosphatidylinositide3kinasepi3kandpi3krelatedkinasepikkactivitycontributestoradioresistanceinthyroidcarcinomas |